Literature DB >> 6614998

Comments on the contribution by H. J. Grill et al. Steroid hormone receptors in melanoma.

F H Rampen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6614998     DOI： 10.1007/bf00510057

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  6 in total

1.  Hormone therapy in malignant melanoma.

Authors:  H Flax; H Salih; G Westbury
Journal:  Lancet       Date:  1973-07-21       Impact factor: 79.321

2.  Endocrine influences on survival from malignant melanoma.

Authors:  H M Shaw; G W Milton; G Farago; W H McCarthy
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

3.  Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma.

Authors:  E T Creagan; J N Ingle; D L Ahmann; S J Green
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

4.  Phase II study of tamoxifen in patients with disseminated malignant melanoma.

Authors:  E T Creagan; J N Ingle; S J Green; D L Ahmann; N S Jiang
Journal:  Cancer Treat Rep       Date:  1980 Feb-Mar

5.  Malignant melanoma: an androgen-dependent tumour?

Authors:  F H Rampen; J H Mulder
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

6.  Malignant melanoma: sex differences in survival after evidence of distant metastasis.

Authors:  F Rampen
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640
  6 in total
  1 in total

Review 1.  Skin steroidogenesis in health and disease.

Authors:  Georgios Nikolakis; Constantine A Stratakis; Theodora Kanaki; Andrej Slominski; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.